alexa Robert J. Nicolosi | University of Massachusetts
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Robert J. Nicolosi

Center for Health and Disease Research-Division of NanoMedicine, Department of Clinical Laboratory and Nutritional Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA

Robert J. Nicolosi, Ph.D, C.N.S is the Chief Science Officer for Designs for Health. Dr. Nicolosi is also President of R J Nicolosi LLC. Dr. Nicolosi was previously Director of the Center for Health and Disease Research and the Division of NanoMedicine at the University of Massachusetts-Lowell. He has many publications.  One of the publications includes “A Self Assembling Nanoemulsion of Lovastatin (SANEL) Decreases Cholesterol Accumulation and Apob-100 Secretion Greater than Lovastatin alone a Hepg2 Cell Line” in the Journal of Nanomedicine & Nanotechnology.

Research Interest

Nanotechnology, Nano biotechnology, Nanomedicine, Nano biopharmaceutics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version